Notification of executives and related parties transactions with Nilfisk shares
In accordance with the EU Market Abuse Regulation Article 19 no. 596/2014, Nilfisk has received the following notification from executives and/or their related parties’ regarding transactions in Nilfisk shares.
This notification is an ‘Initial notification’ regarding the purchase of 1,000 shares in Nilfisk by Chair of The Board of Directors for Nilfisk Holding A/S Peter Göran Nilsson. The shares have been purchased on March 1, 2023 at a total price of 132,000 DKK.
For further information, please contact:
Investor Relations: Elisabeth Toftmann Klintholm +45 2555 6337
Media Relations: Nynne Jespersen Lee +45 4231 0007
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name: Peter Göran Nilsson
2. Reason for notification
a) Occupation / title: Chair of the Board of Directors
b) Initial notification /amendment: Initial notification
3. Further information on the issuer of the securities in question
a) Name: Nilfisk Holding A/S
b) LEI code: 529900FSU45YYVLKB451
4. Further information on transaction/transactions: must be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each marketplace where the transactions have been executed
a) Description of the financial instrument, type of instrument / Securities code: Shares Nilfisk Holding (NLFSK) - ISIN DK0060907293
b) Transaction type: Purchase of shares to market price
c) Price(s) and volume(s)
|DKK 132,00 per share||1,000 shares|
d) Aggregated information
- Aggregated volume: Volume: 1,000
- Aggregated price: Price: DKK 132,000 in total
e) Date of the transaction: March 1, 2023
f) Market place of the transaction: Nasdaq Copenhagen (Copenhagen Stock Exchange)
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Alvotech Provides Update on Corporate Sustainability Framework28.3.2023 11:00:00 CEST | Press release
Alvotech (Nasdaq: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced an update to the Company’s Corporate Sustainability framework, including the release of key environmental, social and governance (“ESG”) indicators for 2022. “As part of our commitment to improve the sustainability of healthcare by providing access to more affordable biologic medicines, we recognize that corporate sustainability is closely linked to our long-term success and the value we may bring to patients, healthcare providers and all of our stakeholders,” said Robert Wessman, Founder, Chairman and CEO of Alvotech. Data on key ESG indicators for 2020-2022 can be found on Alvotech’s dedicated web portal. Alvotech’s Board of Directors has established a Corporate Sustainability Committee (CSC) to oversee the Company’s strategy as it relates to ESG matters. Alvotech’s corporate headquarters, purpose-built manuf
Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP839628.3.2023 10:54:21 CEST | Press release
Company announcement – No. 7 / 2023 Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396 Dose-dependent body weight reductions of up to a mean of 4.2% from baseline (4.8% placebo corrected) following a single dose of ZP8396In development as a non-incretin peptide therapyfor the potential management of overweight and obesity Copenhagen, Denmark, March 28, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078) a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced Phase 1a results for ZP8396, the company’s amylin analogue. The first-in-human study was designed to assess safety, pharmacokinetic (PK) and pharmacodynamic effects of ZP8396 in healthy lean and overweight people. “We are excited by the potential of amylin as an alternative, non-incretin treatment for overweight and obesity, and are very encouraged that treatment with a single dose of ZP8396 led to meaningful dose
Indkaldelse til ordinær generalforsamling i SKAKO A/S28.3.2023 10:50:52 CEST | pressemeddelelse
Til NASDAQ OMX Copenhagen A/S GlobeNewswire Faaborg, den 28. marts 2023 Selskabsmeddelelse nr. 5/2023 Indkaldelse til ordinær generalforsamling i SKAKO A/S SKAKO A/S indkalder til ordinær generalforsamling i selskabet til afholdelse onsdag den 19. april 2023, kl. 15.00 på selskabets adresse. Indkaldelsen er sket jf. selskabets vedtægter § 7 og er tilgængelig på selskabets hjemmeside. Udbytte På baggrund af det stærke resultat i 2022 og kapitalstrukturen i SKAKO A/S pr. 31. december 2022 anbefaler bestyrelsen en udbytteudlodning på DKK 5 pr. aktie svarende til 61,0% af årets resultat og en samlet udbytteudlodning på DKK 15,4 mio. Med en aktiekurs på 62,6 kr. pr. 31. december 2022 svarer det til en udbytteprocent på 8,0%. Udbyttebetalingen vil være et behandlingspunkt på agendaen for den ordinære generalforsamling 19. april 2023. Ex-udbytte dato: 19. april 2023 Optagelsesdato: 20. april 2023 Udbetalingsdato: 24. april 2023 Med venlig hilsen SKAKO A/S Jens Wittrup Willumsen Bestyrelsesfor
Aalborg Boldspilklub A/S indkalder til ordinær generalforsamling28.3.2023 10:50:49 CEST | pressemeddelelse
NASDAQ Copenhagen A/S Børsmeddelelse nr. 2023/06 Aalborg, 28. marts 2023 Vedhæftet indkaldelse og dagsorden til ordinær generalforsamling i Aalborg Boldspilklub A/S onsdag 19. april 2023 kl. 16.00 på Aalborg Portland Park. Venlig hilsen Aalborg Boldspilklub A/S Thomas Bælum Administrerende direktør For yderligere oplysninger: Thomas Bælum 2251 7901 Vedhæftede filer Dagsorden 2023 - Inkl Bilag A og Bilag BAAB_ Brevstemme blanket_GF2023_v5
Ress Life Investments A/S publishes notice for Annual General Meeting28.3.2023 10:44:14 CEST | Press release
Ress Life Investments A/S Nybrogade 12 1203 Copenhagen K Denmark CVR nr. 33593163 www.resslifeinvestments.com To: Nasdaq Copenhagen Date: 28 March 2023 Corporate Announcement 11/2023 Ress Life Investments A/S publishes notice for Annual General Meeting TO THE SHAREHOLDERS OF RESS LIFE INVESTMENTS A/S In accordance with Article 9.8 of the Articles of Association, notice is hereby given of the Annual General Meeting of Ress Life Investments A/S (the "Company") which will take place on Wednesday 19 April 2023 at 10.00 a.m. at Nybrogade 12, 1203 Copenhagen K, Denmark. Shareholders in the Company are invited to participate. Agenda for the Annual General Meeting: 1) Adoption of the annual report 2) Appropriation of profit or loss as recorded in the adopted annual report 3) Election of members of the Board of Directors 4) Approval of the Remuneration Report 5) Approval of remuneration for the Board of Directors for the financial year 2023 6) Authorisation to the board of directors to purchase